Solid-Phase Synthesis of Thermolytic DNA Oligonucleotides Functionalized with a Single 4-Hydroxy-1-butyl or 4-Phosphato-/Thiophosphato-1-butyl Thiophosphate Protecting Group-Reference-Cited by-同舟云学术

Solid-Phase Synthesis of Thermolytic DNA Oligonucleotides Functionalized with a Single 4-Hydroxy-1-butyl or 4-Phosphato-/Thiophosphato-1-butyl Thiophosphate Protecting Group

Published:2007-01-11 Issue:3 Volume:72 Page:805-815
ISSN:0022-3263
Container-title:The Journal of Organic Chemistry
language:en
Short-container-title:J. Org. Chem.

Author:

Grajkowski Andrzej¹,Ausín Cristina¹,Kauffman Jon S.¹,Snyder John¹,Hess Sonja¹,Lloyd John R.¹,Beaucage Serge L.¹

Affiliation:

1. Division of Therapeutic Proteins, Center for Drug Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, Maryland 20892, Lancaster Laboratories, 2425 New Holland Pike, Lancaster, Pennsylvania 17605-2425, and Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, The National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/jo062087y

Reference45 articles.

1. The pro-oligonucleotide approach: solid phase synthesis and preliminary evaluation of model pro-dodecathymidylates

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Cellular Uptake of Oligonucleotides Bearing Glutathione-Labile Protecting Groups;Organic Letters;2019-02-04

2. Effective gene silencing activity of prodrug-type 2′-O-methyldithiomethyl siRNA compared with non-prodrug-type 2′-O-methyl siRNA;Bioorganic & Medicinal Chemistry Letters;2018-07

3. Bioinspired Synthesis of Chiral 3,4-Dihydropyranones via S-to-O Acyl-Transfer Reactions;Organic Letters;2018-02-27

4. Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing;Beilstein Journal of Organic Chemistry;2018-02-19

5. Development of Protecting Groups for Prodrug-Type Oligonucleotide Medicines;Chemical and Pharmaceutical Bulletin;2018